References - - BioPharm International

ADVERTISEMENT

References


BioPharm International


BOOKSAhern TJ, Manning M, eds. Stability of protein pharmaceuticals, part A: chemical and physical pathways of protein degradation. Pharmaceutical biotechnology series, volume 2. New York: Plenum Press; 1992.

Ahern TJ, Manning M, eds. Stability of protein pharmaceuticals, part B: in vivo pathways of degradation and strategies for protein stabilization. Pharmaceutical biotechnology series, volume 2. New York: Plenum Press; 1992.

Avis KE, Wu VL. Biotechnology and biopharmaceutical manufacturing, processing, and preservation. Drug manufacturing technology series, volume 2. Buffalo Grove (IL):Interpharm Press; 1996.

Banga AK. Electrically assisted transdermal and topical drug delivery. London: Taylor & Francis; 1998.

Bontempo J, ed. Development of biopharmaceutical parenteral dosage forms. New York: Marcel Dekker; 1997.

Carpenter, JF, Chang BS, Garzon-Rodriguez W, Randolph TW. Rational design of stabilized lyophilized protein formulations: theory and practice. In: Carpenter JF, Manning MC, editors. Rational design of stable protein formulations: theory and practice. New York: Kluwer/Plenum Press; 2002. p. 109-133.

DeSain C. Documentation basics that support good manufacturing practices. Cleveland (OH): Advanstar Communications; 1993.

Hider RC, Barlow D. Polypeptide and protein drugs: production, characterization, and formulation. Ellis Horwood Ltd: Chichester UK; 1991.

Huxsoll JF. Quality assurance for biopharmaceuticals. New York: John Wiley & Sons; 1994.

Kibbe AH, ed. Handbook of pharmaceutical excipients. Third Ed. Washington, DC: American Pharmaceutical Association; 2000.

McNally EJ, ed. Protein formulation and delivery. New York: Marcel Dekker; 2000.

Rowe RC, Roberts RJ. Intelligent software for product formulation. London: Taylor & Francis; 1998.

Saeb-Parsy K, et al., eds. Instant pharmacology. New York: John Wiley & Sons; 1999.

Wang YJ, Pearlman R, eds. Stability and characterization of protein and peptide drugs: case histories. Pharmaceutical biotechnology series, volume 5. New York: Plenum Press; 1993.

Wang YJ, Pearlman R, eds. Formulation, characterization, and stability of protein drugs: case histories. Pharmaceutical biotechnology series, volume 9. New York: Plenum Press; 1996.


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Novartis Reports Positive Results for Secukinumab in Ankylosing Spondylitis Trials
October 23, 2014
Pall ForteBio Releases Bioprocessing Contamination Detection Kit
October 22, 2014
Roche to Expand and Improve its Basel Site
October 22, 2014
FDA Panel Unanimously Backs Secukinumab for the Treatment of Psoriasis
October 22, 2014
EMA Works to Speed Up Ebola Treatment
October 20, 2014
Author Guidelines
Source: BioPharm International,
Click here